Q1 FY27 Results: Revenue up 251% YoY at Rs. 10.02 crore on consolidated basis
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.9 pts more than Nifty Microcap 250 and 1.2 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board approved Q1 FY27 (June 2026) results. Consolidated revenue from operations jumped 251% YoY to Rs. 10.02 crore from Rs. 2.85 crore, with total revenue at Rs. 10.05 crore. Consolidated PAT grew 125% to Rs. 25.14 lakh (from Rs. 11.16 lakh). EPS at Rs. 0.23 versus Rs. 0.10. Growth is driven by subsidiary KP International. Standalone, however, slipped to a Rs. 5.74 lakh loss versus Rs. 0.75 lakh profit. Auditor N.S. Nanavati and Co issued a clean limited review report.
Strong consolidated growth from subsidiary. Standalone remains weak with a quarterly loss, worth watching.